Carbon Monoxide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11588 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | sclerosing cholangitis | KG + DL |
| 2 | ventricular tachycardia | KG + DL |
| 3 | obsolete bundle branch block | KG + DL |
| 4 | catecholaminergic polymorphic ventricular tachycardia | KG + DL |
| 5 | potassium deficiency disease | KG + DL |
| 6 | neovascular glaucoma | KG + DL |
| 7 | angle-closure glaucoma | KG + DL |
| 8 | pulmonary hypertension | KG + DL |
| 9 | traumatic glaucoma | KG + DL |
| 10 | aqueous misdirection | KG + DL |
| 11 | glaucomatous atrophy of optic disc | KG + DL |
| 12 | arrhythmogenic right ventricular cardiomyopathy | KG + DL |
| 13 | hyperinsulinemic hypoglycemia, familial | KG + DL |
| 14 | kyphoscoliotic heart disease | KG + DL |
| 15 | diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency | KG + DL |
| 16 | autosomal recessive hyperinsulinism due to SUR1 deficiency | KG + DL |
| 17 | autosomal dominant hyperinsulinism due to Kir6.2 deficiency | KG + DL |
| 18 | disorder of carbohydrate absorption and transport | KG + DL |
| 19 | periodic paralysis with transient compartment-like syndrome | KG + DL |
| 20 | incessant infant ventricular tachycardia | KG + DL |
| 21 | gastroparesis (disease) | KG + DL |
| 22 | autosomal recessive hyperinsulinism due to Kir6.2 deficiency | KG + DL |
| 23 | familial visceral myopathy | KG + DL |
| 24 | congenital isolated hyperinsulinism | KG + DL |
| 25 | hyperinsulinemic hypoglycemia | KG + DL |
| 26 | postural orthostatic tachycardia syndrome | KG + DL |
| 27 | Meniere disease | KG + DL |
| 28 | autosomal dominant hyperinsulinism due to SUR1 deficiency | KG + DL |
| 29 | somatostatinoma | KG + DL |
| 30 | endolymphatic hydrops | KG + DL |
| 31 | diazoxide-resistant hyperinsulinism | KG + DL |
| 32 | functional pancreatic neuroendocrine tumor | KG + DL |
| 33 | primary hereditary glaucoma | KG + DL |
| 34 | otosclerosis | KG + DL |
| 35 | open-angle glaucoma | KG + DL |
| 36 | pancreatic neuroendocrine tumor G1 | KG + DL |
| 37 | peripheral vertigo | KG + DL |
| 38 | idiopathic bronchiectasis | KG + DL |
| 39 | age-related hearing impairment | KG + DL |
| 40 | non-functional pancreatic neuroendocrine tumor | KG + DL |
| 41 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 42 | PPoma | KG + DL |
| 43 | GRFoma | KG + DL |
| 44 | neonatal thyrotoxicosis | KG + DL |
| 45 | hypotrichosis simplex of the scalp | KG + DL |
| 46 | pancreatic gastrin-producing neuroendocrine tumor | KG + DL |
| 47 | Graves disease | KG + DL |
| 48 | rhinitis | KG + DL |
| 49 | postgastrectomy syndrome | KG + DL |
| 50 | active cochleovestibular Meniere disease | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.